Back to Previous Page
New SearchHide Search
In the face of a global crisis, Novartis has quickly mobilized R&D capabilities, medicines, clinical trials expertise and philanthropic aid to address the coronavirus pandemic.
This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.
You are here
This site is intended for a global audience.